Purpose of this notice To ensure users of certain nucleic acid testing NAT technologies are aware of certain aspects of the instructions for use IFU for all products Description of the problem WHO has received user feedback on an elevated risk for false SARS CoV 2 results when testing specimens using RT PCR reagents on open system